Wuxi Biologics USA LLC is the U.S. arm of a biotechnology company based in China that provides services to develop and manufacture biological medicines. Its filings show it spent about $300,000 across four reports lobbying Congress and the federal government on economic development and health issues, mainly providing company updates and supporting introductions to lawmakers and administration officials. It hired FGS Global to do this work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ADAM GOLDSTEIN
The latest disclosures for this client.
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Q2FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
BRETT O'BRIEN
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
KERRY O'BRIEN
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Q4FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Q3FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Q2FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
Q1